Mimi I Hu MDAssociate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dr. Mimi I. Hu is an endocrinologist practicing in Houston, Texas. She is Associate Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center. She is also Clinical Assistant Professor in the Department of Internal Medicine at Texas A&M Health Science Center College of Medicine in Houston.
After receiving her medical degree from The University of Texas Houston Health Science Center Medical School, she completed her residency and endocrine fellowship at Baylor College of Medicine, where she also served as chief medical resident. After completion of her research fellowship at MD Anderson, she joined the faculty in 2007 in the department of Endocrine Neoplasia and Hormonal Disorders. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma, hereditary endocrine neoplasia disorders, and metabolic bone and mineral disorders. Her research focuses on novel therapeutics for thyroid cancer, medullary thyroid cancer, and bone and mineral metabolism disorders. Dr. Hu is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma.
Dr. Hu has published 90 articles and abstracts on the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, endocrine complications of head and neck surgery, and paraneoplastic endocrine disorders. Among other professional organizations, she is a member of the American Association of Clinical Endocrinologists, American Society of Clinical Oncology, American Thyroid Association, and Endocrine Society.
DisclosuresDr. Mimi Hu reports no disclosures.
Recent Contributions to PracticeUpdate:
- Determining Which Post-Operative Therapy to Use and the Future of MTC—Expert Video 5 of 5
- Using Cabozantinib to Treat Medullary Thyroid Cancer—Expert Video 4 of 5
- Medullary Thyroid Cancer: Post-Operative Monitoring and When to Consider Therapy—Expert Video 2 of 5
- Using Vandetanib to Treat Medullary Thyroid Cancer—Expert Video 3 of 5
- Medullary Thyroid Cancer and Its Primary Treatment—Expert Video 1 of 5